Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high‐risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin‐converting enzyme inhibitor dose at discharge
- 1 March 2001
- journal article
- clinical trial
- Published by Wiley in European Journal of Heart Failure
- Vol. 3 (2) , 209-215
- https://doi.org/10.1016/s1388-9842(00)00134-3
Abstract
Despite a growing body of data demonstrating the benefits of multidisciplinary care in heart failure, persistently high rates of readmission, especially within the first month of discharge, continue to be documented. As part of an ongoing randomized study on the value of multidisciplinary care in a high risk (NYHA Class IV), elderly (mean age 69 years) heart failure population, we examined the effects of this intervention on previously high (20%) 1-month readmission rates. Unlike previous studies of this approach, both multidisciplinary (MC) and routine care (RC) populations were cared for by the cardiology service, complied with adherence to clinical stability criteria prior to discharge (100% of patients) and received at least target dose angiotensin-converting enzyme (ACE) inhibition with perindopril prior to discharge (94% of indicated patients). We analysed death and unplanned readmission for heart failure at 1 month. This early report from the first 70 patients (67% male, 71% systolic dysfunction with a mean ejection fraction of 31.0+/-6.7%) enrolled in this study demonstrates elimination of 1-month hospital readmission in both RC and MC groups. This unexpected result represents a dramatic improvement both for this patient cohort (20% 30-day readmission rate prior to enrollment reduced to 0% following the index admission in both care groups) and in comparison with available data. Critical contributors to this improvement appear to be specialist cardiology care, adherence to clinical stability criteria prior to discharge and routine use of target or high-dose ACE inhibitor therapy prior to discharge. Widespread application of this approach may have a dramatic improvement in morbidity of CHF while limiting the escalating costs of this condition.Keywords
This publication has 23 references indexed in Scilit:
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- Simple clinical variables are markers of the propensity for early readmissions in heart failure patientsJournal of Cardiac Failure, 1999
- Undertreatment of older patients with congestive heart failureJournal of Cardiac Failure, 1999
- Effects of education and support on self-care and resource utilization in patients with heart failurePublished by Oxford University Press (OUP) ,1999
- The independent effects of left ventricular ejection fraction on short‐term outcomes and resource utilization following hospitalization for heart failureClinical Cardiology, 1999
- Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failureJournal of General Internal Medicine, 1997
- Does Increased Access to Primary Care Reduce Hospital Readmissions?New England Journal of Medicine, 1996
- The heart failure epidemic: magnitude of the problem and potential mitigating approachesCurrent Opinion in Cardiology, 1996
- Differing Early Blood Pressure and Renin-Angiotensin System Responses to the First Dose of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1996
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995